These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20864675)

  • 21. Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA.
    Rodríguez-González R; Agulla J; Pérez-Mato M; Sobrino T; Castillo J
    Neurochem Int; 2011 Feb; 58(3):337-43. PubMed ID: 21163314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.
    Haile WB; Wu J; Echeverry R; Wu F; An J; Yepes M
    J Cereb Blood Flow Metab; 2012 Jan; 32(1):57-69. PubMed ID: 21792242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.
    Wu F; Echeverry R; Wu J; An J; Haile WB; Cooper DS; Catano M; Yepes M
    Mol Cell Neurosci; 2013 Jan; 52():9-19. PubMed ID: 23063501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retina Is Protected by Neuroserpin from Ischemic/Reperfusion-Induced Injury Independent of Tissue-Type Plasminogen Activator.
    Gu RP; Fu LL; Jiang CH; Xu YF; Wang X; Yu J
    PLoS One; 2015; 10(7):e0130440. PubMed ID: 26176694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
    Fabbro S; Schaller K; Seeds NW
    J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse.
    Krueger SR; Ghisu GP; Cinelli P; Gschwend TP; Osterwalder T; Wolfer DP; Sonderegger P
    J Neurosci; 1997 Dec; 17(23):8984-96. PubMed ID: 9364046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin.
    Lebeurrier N; Launay S; Macrez R; Maubert E; Legros H; Leclerc A; Jamin SP; Picard JY; Marret S; Laudenbach V; Berger P; Sonderegger P; Ali C; di Clemente N; Vivien D
    J Cell Sci; 2008 Oct; 121(Pt 20):3357-65. PubMed ID: 18796535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes.
    Makarova A; Mikhailenko I; Bugge TH; List K; Lawrence DA; Strickland DK
    J Biol Chem; 2003 Dec; 278(50):50250-8. PubMed ID: 14522960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
    Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological and pathological functions of neuroserpin: Regulation of cellular responses through multiple mechanisms.
    Lee TW; Tsang VW; Loef EJ; Birch NP
    Semin Cell Dev Biol; 2017 Feb; 62():152-159. PubMed ID: 27639894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain.
    Fabbro S; Seeds NW
    J Neurochem; 2009 Apr; 109(2):303-15. PubMed ID: 19222708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.
    Zhang X; Polavarapu R; She H; Mao Z; Yepes M
    Am J Pathol; 2007 Oct; 171(4):1281-90. PubMed ID: 17717150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system.
    Teesalu T; Kulla A; Simisker A; Sirén V; Lawrence DA; Asser T; Vaheri A
    Thromb Haemost; 2004 Aug; 92(2):358-68. PubMed ID: 15269833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background.
    Tabrizi P; Wang L; Seeds N; McComb JG; Yamada S; Griffin JH; Carmeliet P; Weiss MH; Zlokovic BV
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2801-6. PubMed ID: 10559029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspective.
    Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Alnaaim SA; Alexiou A; Papadakis M; Saad HM; Batiha GE
    Acta Neurol Belg; 2024 Apr; 124(2):377-388. PubMed ID: 37917293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AAV-mediated overexpression of neuroserpin in the hippocampus decreases PSD-95 expression but does not affect hippocampal-dependent learning and memory.
    Tsang VW; Young D; During MJ; Birch NP
    PLoS One; 2014; 9(3):e91050. PubMed ID: 24608243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-type plasminogen activator mediates neuronal detection and adaptation to metabolic stress.
    Wu F; Nicholson AD; Haile WB; Torre E; An J; Chen C; Lee AK; Duong DM; Dammer EB; Seyfried NT; Tong FC; Votaw JR; Yepes M
    J Cereb Blood Flow Metab; 2013 Nov; 33(11):1761-9. PubMed ID: 23881246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
    Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
    J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.